Outcome of Court Hearing on Reduction of Capital

Breedon Group PLC
06 June 2023
 

6 June 2023

LEI: 213800DQGNQE3X76WS92

BREEDON GROUP PLC

(the "Company")

Outcome of Court Hearing on Reduction of Capital

The Company announces that the reduction of capital involving: (i) the reduction of the nominal value of the ordinary shares of £1.40 each in the capital of the Company to £0.01 each, (ii) the cancellation of the 14,286 subscription shares of £3.50 each in the capital of the Company, and (iii) the cancellation of the share premium account of the Company (the "Capital Reduction") was approved earlier today by the High Court of Justice of England and Wales (the "Court").

Details of the Capital Reduction were set out in the prospectus of the Company dated 11 May 2023.

The Court order approving the Capital Reduction and a statement of capital approved by the Court are expected to be registered by the Registrar of Companies no later than Tuesday 20 June 2023.

The Capital Reduction will not affect the number of ordinary shares in issue. Assuming that no further shares are issued prior to the Capital Reduction becoming effective, the issued share capital of the Company following the Capital Reduction is expected to consist of 338,901,668 ordinary shares of £0.01 each.

Enquiries:

Breedon Group plc

+44 (0) 1332 694010

Rob Wood, Chief Executive Officer


James Brotherton, Chief Financial Officer


Louise Turner-Smith, Head of Investor Relations

+44 (0) 7860 911909

 


MHP (Public relations adviser)

+44 (0) 20 3128 8193

Reg Hoare, Rachel Farrington, Charles Hirst

breedon@mhpgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings